CN
Proprietary Technology
Our Proprietary Technologies Provide Solutions for Unmet Clinical Needs in Dermatology
HOME > Proprietary Technology
PROPRIETARY TECHNOLOGY
Unlocking Transdermal Delivery: The Power of Crystal Engineering and Polymer Science
Follicular Target Drug Delivery

Formulation using Nanocrystals or Nanoemulsions

3D Crystal Structure Design and Modulation by Polymeric Additives

By utilizing polymers as crystal nucleation and growth modifier, we can significantly reduce the amount of crystal growth regulators while maintaining the pharmaceutical and texture properties of the drug product, enabling easy enhancement of drug solubility and control of gritty sensation.


Multilevel Porous Polymeric Structure for Drug Delivery & Controlled Release

Our innovative multidimensional microporous polymers provide a versatile platform for the precise control of drug release, allowing for the combination of multiple drugs in a single system.


Nanocrystal / Nano-Emulsion Drug Delivery Technology via Dermal and Follicular Routes

Our nanocrystal/nanoemulsion hair follicle transdermal delivery system offers enhanced skin penetration and sustained drug release, maximizing therapeutic efficacy.


SoliTech® Innovation Institute is a nationally accredited innovation hub. The institute concentrates on topical and transdermal drug delivery, delving deep into the design and control of micro-delivery systems. The institute is organized into four centers: Polymorph & Crystallization, Topical and Transdermal Drug Delivery, Complex Generics, and Accelerated FIH Development.
This laboratory is accredited as National-level Postdoctoral Research Workstation, Provincial Research Institute for Topical and Transdermal Drugs, and Provincial Research Center for Highly Variable Drugs.

●   Form Screening and Crystallization Development

 

●   Control of Solid Form in Finished Products

 

●   Crystal Growth of Polymeric Additives

●  Formulation Development for Poorly Soluble Drugs

 

●  Formulation Development for Poorly Permeable Drugs

 

●  Formulation Development for Reactive Molecules


●  Development of New Permeation Enhancer

 

● Follicular Target Delivery

 

● Extended Release for Topicals


●  Semi-Solids

 

●  Fixed Dose Combination

 

●  Formulation with Complex APIs


Polymorph & Crystallization
Accelerated FIH Development
Topic and Transdermal Drug Delivery
Complex Generics